Skip to main content
. 2017 Dec 13;7:17530. doi: 10.1038/s41598-017-17836-7

Figure 5.

Figure 5

(A) Association of UBE2T and DTL individually with first progression survival in stage I Lung Adenocarcinoma tumors. (B) Association of the combined analyses of UBE2T and DTL with first progression survival in stage I Lung Adenocarcinoma tumors. (C) Association of the combined analyses of UBE2T and DTL with overall survival in stage I Lung Adenocarcinoma tumors.